abstract |
The present application relates to a method for treating diseases and disorders related to deazapurine, thienopyrimidine and furopyrimidine, and phosphoinositide 3-kinase with zinc binding moiety based derivatives, for example in the treatment of cancer And their use. The present application further relates to the treatment of histone deacetylase related disorders and diseases associated with both histone deacetylase and phosphoinositide 3-kinase. |